AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-78
Results: 51-75/78
COMPARISON OF SERUM HEPATITIS-C VIRUS-RNA CONCENTRATION BY BRANCHED DNA-PROBE ASSAY WITH COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AS A PREDICTOR OF RESPONSE TO INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS-C PATIENTS
Authors: TOYODA H NAKANO S KUMADA T TAKEDA I SUGIYAMA K OSADA T KIRIYAMA S ORITO E MIZOKAMI M
Citation: H. Toyoda et al., COMPARISON OF SERUM HEPATITIS-C VIRUS-RNA CONCENTRATION BY BRANCHED DNA-PROBE ASSAY WITH COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AS A PREDICTOR OF RESPONSE TO INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS-C PATIENTS, Journal of medical virology, 48(4), 1996, pp. 354-359
HEPATITIS-G VIRUS IN IMMUNOSUPPRESSED PEDIATRIC ALLOGRAFT RECIPIENTS
Authors: KUDO T MORISHIMA T TSUZUKI K ORITO E MIZOKAMI M
Citation: T. Kudo et al., HEPATITIS-G VIRUS IN IMMUNOSUPPRESSED PEDIATRIC ALLOGRAFT RECIPIENTS, Lancet, 348(9029), 1996, pp. 751-751
GENOTYPE, SERUM LEVEL OF HEPATITIS-C VIRUS-RNA AND LIVER HISTOLOGY ASPREDICTORS OF RESPONSE TO INTERFERON-ALPHA 2A THERAPY IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS-C
Authors: MIZOKAMI M ORITO E GIBO Y SUZUKI K OHBA K OHNO T LAU JYN
Citation: M. Mizokami et al., GENOTYPE, SERUM LEVEL OF HEPATITIS-C VIRUS-RNA AND LIVER HISTOLOGY ASPREDICTORS OF RESPONSE TO INTERFERON-ALPHA 2A THERAPY IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS-C, Liver, 16(1), 1996, pp. 23-27
QUANTIFICATION OF SERUM HEPATITIS-C VIRUS CORE PROTEIN LEVEL IN PATIENTS CHRONICALLY INFECTED WITH DIFFERENT HEPATITIS-C VIRUS GENOTYPES
Authors: ORITO E MIZOKAMI M TANAKA T LAU JYN SUZUKI K YAMAUCHI M OHTA Y HASEGAWA A TANAKA S KOHARA M
Citation: E. Orito et al., QUANTIFICATION OF SERUM HEPATITIS-C VIRUS CORE PROTEIN LEVEL IN PATIENTS CHRONICALLY INFECTED WITH DIFFERENT HEPATITIS-C VIRUS GENOTYPES, Gut, 39(6), 1996, pp. 876-880
EVOLUTIONARY RELATIONSHIP OF HEPATITIS-C, PESTIVIRUSES, FLAVIVIRUSES,PLANTVIRUSES, AND NEWLY DISCOVERED GB HEPATITIS AGENTS
Authors: OHBA K MIZOKAMI M LAU JYN ORITO E IKEO K GOJOBORI T
Citation: K. Ohba et al., EVOLUTIONARY RELATIONSHIP OF HEPATITIS-C, PESTIVIRUSES, FLAVIVIRUSES,PLANTVIRUSES, AND NEWLY DISCOVERED GB HEPATITIS AGENTS, FEBS letters, 378(3), 1996, pp. 232-234
GENOTYPE DISTRIBUTION IN NAGOYA AND NEW GENOTYPE (GENOTYPE 3A) IN JAPANESE PATIENTS WITH HEPATITIS-C VIRUS
Authors: OHNO T MIZOKAMI M YAMAUCHI M OHBA KI ORITO E WU RR MIZUNO M SUGIHARA K WAKITA T KAKUMU S
Citation: T. Ohno et al., GENOTYPE DISTRIBUTION IN NAGOYA AND NEW GENOTYPE (GENOTYPE 3A) IN JAPANESE PATIENTS WITH HEPATITIS-C VIRUS, Journal of gastroenterology, 30(2), 1995, pp. 209-214
CYSTIC LYMPHANGIOMA OF THE GALLBLADDER - A CASE-REPORT
Authors: OHBA K SUGAUCHI F ORITO E SUZUKI K OHNO T MIZOGUCHI N KOIDE T TERASHIMA H NAKANO T MIZOKAMI M
Citation: K. Ohba et al., CYSTIC LYMPHANGIOMA OF THE GALLBLADDER - A CASE-REPORT, Journal of gastroenterology and hepatology, 10(6), 1995, pp. 693-696
HEPATITIS-C VIRUS GENOTYPE-7, GENOTYPE-8, AND GENOTYPE-9 SHOULD BE CLASSIFIED AS GENOTYPE-6 SUBTYPES
Authors: MIZOKAMI M GE XM HOTTA H WANG SS WANG Y PAN HD HUANG GY WU RR CAO K OHBA KI ORITO E LAU JYN
Citation: M. Mizokami et al., HEPATITIS-C VIRUS GENOTYPE-7, GENOTYPE-8, AND GENOTYPE-9 SHOULD BE CLASSIFIED AS GENOTYPE-6 SUBTYPES, Hepatology, 22(4), 1995, pp. 951-951
MOLECULAR EPIDEMIOLOGY OF HEPATITIS-C INFECTION AMONG INTRAVENOUS-DRUG-USERS IN GUANGXI PROVINCE, SOUTHERN CHINA
Authors: MIZOKAMI M GE XM WANG SS WANG Y PAN HD HUANG GY WU RR CAO K ORITO E LAU JYN
Citation: M. Mizokami et al., MOLECULAR EPIDEMIOLOGY OF HEPATITIS-C INFECTION AMONG INTRAVENOUS-DRUG-USERS IN GUANGXI PROVINCE, SOUTHERN CHINA, Hepatology, 22(4), 1995, pp. 953-953
SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA
Authors: TANAKA T LAU JYN MIZOKAMI M ORITO E TANAKA E KIYOSAWA K YASUI K OHTA Y HASEGAWA A TANAKA S KOHARA M
Citation: T. Tanaka et al., SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA, Hepatology, 22(4), 1995, pp. 996-996
SIGNIFICANCE OF SERUM HEPATITIS-C VIRUS CORE PROTEIN LEVEL IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: ORITO E MIZOKAMI M SUZUKI K OHBA K OHNO T KOIDE T NAKANO T LAU JYN TANAKA T TANAKA S KOHARA M
Citation: E. Orito et al., SIGNIFICANCE OF SERUM HEPATITIS-C VIRUS CORE PROTEIN LEVEL IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 22(4), 1995, pp. 1452-1452
SIMPLE FLUORESCENT ENZYME-IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA
Authors: TANAKA T LAU JYN MIZOKAMI M ORITO E TANAKA E KIYOSAWA K YASUI K OHTA Y HASEGAWA A TANAKA S KOHARA M
Citation: T. Tanaka et al., SIMPLE FLUORESCENT ENZYME-IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA, Journal of hepatology, 23(6), 1995, pp. 742-745
RELATIONSHIP BETWEEN THE PRESENCE OF CIRCULATING ANTI-GOR AND HEPATITIS-C VIREMIA GENOTYPE
Authors: LAU JYN MIZOKAMI M DAVIS GL KOLBERG JA URDEA MS ORITO E POLITO A DINELLO R QUAN S
Citation: Jyn. Lau et al., RELATIONSHIP BETWEEN THE PRESENCE OF CIRCULATING ANTI-GOR AND HEPATITIS-C VIREMIA GENOTYPE, Journal of hepatology, 22(6), 1995, pp. 707-707
RELATIONSHIPS BETWEEN SEROTYPES AND GENOTYPES OF HEPATITIS-B VIRUS - GENETIC CLASSIFICATION OF HBV BY USE OF SURFACE GENES
Authors: OHBA KI MIZOKAMI M OHNO T SUZUKI K ORITO E LAU JYN INA Y IKEO K GOJOBORI T
Citation: Ki. Ohba et al., RELATIONSHIPS BETWEEN SEROTYPES AND GENOTYPES OF HEPATITIS-B VIRUS - GENETIC CLASSIFICATION OF HBV BY USE OF SURFACE GENES, Virus research, 39(1), 1995, pp. 25-34
CLASSIFICATION OF HEPATITIS-C VIRUS INTO MAJOR TYPES AND SUBTYPES BASED ON MOLECULAR EVOLUTIONARY ANALYSIS
Authors: OHBA K MIZOKAMI M OHNO T SUZUKI K ORITO E INA Y LAU JYN GOJOBORI T
Citation: K. Ohba et al., CLASSIFICATION OF HEPATITIS-C VIRUS INTO MAJOR TYPES AND SUBTYPES BASED ON MOLECULAR EVOLUTIONARY ANALYSIS, Virus research, 36(2-3), 1995, pp. 201-214
LOSS OF SERUM HCV RNA AT WEEK-4 OF INTERFERON-ALPHA THERAPY IS ASSOCIATED WITH MORE FAVORABLE LONG-TERM RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: ORITO E MIZOKAMI M SUZUKI K OHBA K OHNO T MORI M HAYASHI K KATO K IINO S LAU JYN
Citation: E. Orito et al., LOSS OF SERUM HCV RNA AT WEEK-4 OF INTERFERON-ALPHA THERAPY IS ASSOCIATED WITH MORE FAVORABLE LONG-TERM RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS-C, Journal of medical virology, 46(2), 1995, pp. 109-115
PREDICTORS OF RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN CHRONIC HEPATITIS-C
Authors: BENNETT WG ORITO E MIZOKAM M LA JYN
Citation: Wg. Bennett et al., PREDICTORS OF RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN CHRONIC HEPATITIS-C, Gastroenterology, 108(4), 1995, pp. 1034-1034
2 OVERLAPPING IMMUNODOMINANT B-CELL EPITOPES IN HCV CORE ANTIGEN IDENTIFIED BY MONOCLONAL-ANTIBODY MAPPING
Authors: MIZOKAMI M ORITO E OHBA K HASEGAWA A OHBA Y KOHARA M LAU JYN
Citation: M. Mizokami et al., 2 OVERLAPPING IMMUNODOMINANT B-CELL EPITOPES IN HCV CORE ANTIGEN IDENTIFIED BY MONOCLONAL-ANTIBODY MAPPING, Gastroenterology, 108(4), 1995, pp. 1124-1124
CHRONIC HEPATITIS-C COMPLICATED BY COOMBS-NEGATIVE HEMOLYTIC-ANEMIA DURING INTERFERON TREATMENT
Authors: HIRASHIMA N MIZOKAMI M ORITO E YAMAUCHI M NARITA M MIZUNO M TOKUDA Y NAKANO T KATO M MATSUMOTO T SUGIHARA K KOYAMA K YOSHIDA A OGINO M
Citation: N. Hirashima et al., CHRONIC HEPATITIS-C COMPLICATED BY COOMBS-NEGATIVE HEMOLYTIC-ANEMIA DURING INTERFERON TREATMENT, Internal medicine, 33(5), 1994, pp. 300-302
PREDICTORS OF LONG-TERM RESPONSE TO INTERFERON-ALPHA THERAPY IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS-C
Authors: MIZOKAMI M ORITO E SUSUKI K OHBA K OHNO T MIZOGUCHI N KOIDE T TERASHIMA H NAKANO T URDEA M LAU JYN
Citation: M. Mizokami et al., PREDICTORS OF LONG-TERM RESPONSE TO INTERFERON-ALPHA THERAPY IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 20(4), 1994, pp. 10000158-10000158
LATE COMPLETE AND SUSTAINED RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS (HCV) INFECTION
Authors: ORITO E MIZOKAMI M SUZUKI N OHBA K OHNO T MIZOGUCHI N KOIDE T TERASHIMA H NAKANO T IINO S LAU JYN
Citation: E. Orito et al., LATE COMPLETE AND SUSTAINED RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS (HCV) INFECTION, Hepatology, 20(4), 1994, pp. 10000159-10000159
INTERFERON-ALPHA (IFN) THERAPY EXERTS SELECTIVE PRESSURE ON HEPATITIS-C VIRUS (HCV) QUASI-SPECIES
Authors: LAU JYN OHNO T OHBA K ORITO E SUZUKI K DAVIS GL MIZOKAMI M
Citation: Jyn. Lau et al., INTERFERON-ALPHA (IFN) THERAPY EXERTS SELECTIVE PRESSURE ON HEPATITIS-C VIRUS (HCV) QUASI-SPECIES, Hepatology, 20(4), 1994, pp. 10000167-10000167
A NEW HEPATITIS-C VIRUS (HCV) GENOTYPING SYSTEM THAT ALLOWS FOR THE IDENTIFICATION OF HCV GENOTYPE-3, GENOTYPE-4A AND GENOTYPE-5A
Authors: OHNO T MIZOKAMI M ORITO E WU RR SUZUKI KI OHBA K MIZOGUCHI N KOIDE T KIYOSAWA K GOJOBORI T YANO M FANG ZX DAVIS GL ALQUAIZ MN PEREIRA LMMB TIPPS CJ WILLIAMS R LAU JYN
Citation: T. Ohno et al., A NEW HEPATITIS-C VIRUS (HCV) GENOTYPING SYSTEM THAT ALLOWS FOR THE IDENTIFICATION OF HCV GENOTYPE-3, GENOTYPE-4A AND GENOTYPE-5A, Hepatology, 20(4), 1994, pp. 10000243-10000243
DISTRIBUTION OF HEPATITIS-C VIRUS (HCV) SEROLOGICALLY DEFINED GENOTYPES IN 4 CONTINENTS
Authors: MIZOGUCHI N MIZOKAMI M ORITO E KOHARA M LIN HH CHEN DS FANG ZX YOON SK KIM BS COOKSLEY WGE DAVIS GL TIBBS CJ WILLIAMS R LAU JYN
Citation: N. Mizoguchi et al., DISTRIBUTION OF HEPATITIS-C VIRUS (HCV) SEROLOGICALLY DEFINED GENOTYPES IN 4 CONTINENTS, Hepatology, 20(4), 1994, pp. 10000246-10000246
HEPATITIS-C VIRUS SEROTYPE-II RESPONDS MORE FAVORABLY TO INTERFERON-ALPHA THERAPY
Authors: ORITO E MIZOKAMI M MIZOGUCHI N OHBA KI TOHNAI M YAMANAKA H OGURI T HIRASHIMA N KOIDE T KANO H TSUKIYAMAKOHARA K KOHARA M LAU JYN
Citation: E. Orito et al., HEPATITIS-C VIRUS SEROTYPE-II RESPONDS MORE FAVORABLY TO INTERFERON-ALPHA THERAPY, Journal of hepatology, 21(1), 1994, pp. 130-132
Risultati: 1-25 | 26-50 | 51-75 | 76-78